Centene Corp is a leading healthcare enterprise that specializes in providing a range of services designed to enhance the quality, accessibility, and affordability of healthcare for individuals and families, particularly those in underserved communities. The company primarily operates within the managed care sector, offering government-sponsored healthcare programs such as Medicaid and Medicare, as well as health insurance marketplace offerings. Centene's commitment to addressing the diverse needs of its members is underscored by its focus on innovative care models, integrated services, and a dedication to improving health outcomes through personalized support and a deep understanding of local health systems. Read More
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Shares of Centene are trading lower on Thursday, hitting a new 52-week low. A rival's profit warning fueled investor anxiety over government-sponsored healthcare.
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
NEW YORK - July 17, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Centene Corporation (NYSE: CNC) of a class action securities lawsuit.
The health insurer now expects its adjusted net income per diluted share to be approximately $30.00, down from its previous guidance of $34.15 to $34.85.
NEW YORK - July 16, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Centene Corporation (NYSE: CNC) of a class action securities lawsuit.
Glancy Prongay & Murray LLP reminds investors of the upcoming September 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “Class Period”).
UnitedHealth extended its 15-year earnings beat streak in 2024 with $3.3 billion in asset sales, raising questions about financial reporting and deal transparency.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Centene To Contact Him Directly To Discuss Their Options
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.
Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Centene Corporation (CNC) To Contact Him Directly To Discuss Their Options
SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Centene Corporation (NYSE: CNC) securities between December 12, 2024 and June 30, 2025. Centene describes itself as a leading healthcare enterprise that is committed to helping people live healthier lives.
NEW YORK - July 15, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Centene Corporation (NYSE: CNC) of a class action securities lawsuit.
Law Offices of Howard G. Smith reminds investors of the upcoming September 8, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “Class Period”).
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Centene Corporation (NYSE: CNC) securities between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”). Centene is a healthcare company.
